Pfizer Inc. and Celldex Therapeutics Inc. ’s said 70 percent of patients getting their experimental brain tumor vaccine were alive without their cancer worsening about eight months after diagnosis, a study found.
Dendreon Corp. won approval for its only product, the prostate cancer vaccine Provenge, concluding a three-year battle with U.S. regulators to introduce the first therapy to train the body’s immune system to destroy tumors.
Micromet Inc. , a 17-year-old biotechnology company with no medicines on the market, is attracting attention from product-hungry drugmakers. The lure: a technology for fighting cancer without using toxic chemicals.
Pharmacyclics Inc., the cancer-drug maker that announced a deal with Johnson & Johnson yesterday, fell the most in 19 months after RBC Capital Markets said the transaction means it is unlikely to be acquired.